Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H22ClN3O2 |
Molecular Weight | 299.796 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
InChI
InChIKey=TTWJBBZEZQICBI-UHFFFAOYSA-N
InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)
Molecular Formula | C14H22ClN3O2 |
Molecular Weight | 299.796 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:49 UTC 2023
by
admin
on
Fri Dec 15 15:12:49 UTC 2023
|
Record UNII |
L4YEB44I46
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
17.2
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
||
|
NDF-RT |
N0000175799
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
||
|
WHO-VATC |
QA03FA01
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
||
|
WHO-ATC |
A03FA01
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
||
|
LIVERTOX |
NBK548630
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
||
|
NDF-RT |
N0000175800
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB08902MIG
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
D008787
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
L4YEB44I46
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
m7489
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000091624
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
7841
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
4168
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
1782
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
364-62-5
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
241
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
METOCLOPRAMIDE
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL86
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
C62046
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
1740
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
DB01233
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
DTXSID6045169
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
L4YEB44I46
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
6915
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
107736
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
206-662-9
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY | |||
|
Metoclopramide
Created by
admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO AND IN VIVO
|
||
|
METABOLITE -> PARENT |
IN VITRO AND IN VIVO
|
||
|
METABOLITE -> PARENT |
IN VITRO AND IN VIVO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
SINGLE ORAL ADMINISTRATION |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
Population PHARMACOKINETIC PHARMACOKINETIC |
|
||